Bavarian Nordic A/S is a global vaccine company specializing in innovative vaccines to improve public health, particularly in travel health and public preparedness against diseases like mpox and ...
GlaxoSmithKline (GSK) has sold off two travel vaccines to Bavarian Nordic, as the company shifts its focus away from drugs it acquired through a multi-billion “asset swap” deal with Novartis a ...
Order Book for 2025: DKK 2.4 billion. Bavarian Nordic AS (BVNKF) reported strong growth in its travel health portfolio, surpassing revenue consensus for travel health and public preparedness.